Similar Papers

Paper Title
Journal
Date
Author
Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea.
Hilal Kaya Erdogan ... Muzaffer Bilgin
Advances in Dermatology and Allergology | VOL. 35
Hilal Kaya Erdogan, et. al.Hilal Kaya Erdogan ... Muzaffer Bilgin
01 Jan 2018
Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis
Gülden Baskol ... Hüseyin Demir
Cell Biochemistry and Function | VOL. 24
Gülden Baskol, et. al.Gülden Baskol ... Hüseyin Demir
01 Jan 2006
The correlation between serum levels of oxidative stress indicators and renal interstitial fibrosis in patients with IgA nephropathy
...
-
, et. al. ...
15 May 2019
ADENOSINE DEAMINASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Inayet Gunturk ... Emre Ersoy
Sağlık Bilimleri Dergisi | VOL. 31
Inayet Gunturk, et. al.Inayet Gunturk ... Emre Ersoy
26 Dec 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor - 2025.
Josef Smolen
Annals of the rheumatic diseases | VOL. 84
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis.
Francis Berenbaum ... Marc Buyse
Annals of the rheumatic diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.